🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Rationale: COPD is increasing in prevalence among people living with HIV/AI...
Status
Completed
Location
Makerere University Lung Institute
Start Date
2022-04-01
Trial ID
NCT05223114
Treatments Being Tested
This multicenter registry study aims to clarify the incidence trends of int...
Status
Recruiting
Location
Xuanwu Hospital
Start Date
2026-05-18
Trial ID
NCT07604688
Treatments Being Tested
This is a cohort study to understand the changes of breastmilk composition ...
Status
Completed
Location
Nanjing Medical University Jiangning Campus
Start Date
2021-11-19
Trial ID
NCT05235412
Treatments Being Tested
The efficacy and safety of edoxaban has not been adequately studied in Asia...
Status
Unknown
Location
Samsung Medical Center
Start Date
2018-04-20
Trial ID
NCT03554837
This study will collect the data from existing patient medical records at U...
Status
Completed
Location
Research Site
Start Date
2023-07-10
Trial ID
NCT05775549
Treatments Being Tested
The investigators hypothesize that weight loss obtained with the French RNP...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-07-15
Trial ID
NCT05857319
Treatments Being Tested
The Consortium's overall mission can be summarized as follows; each functio...
Status
Completed
Location
Denver VA Medical Center
Start Date
2010-09
Trial ID
NCT01502319
Treatments Being Tested
This study will evaluate obesity-mediated mechanisms of pancreatic carcinog...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2023-02-22
Trial ID
NCT05687188
Treatments Being Tested
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
The main purpose of this study is to assess ustekinumab's ability to induce...
Status
Completed
Location
Universitetssjukhuset Orebro
Start Date
2017-10-25
Trial ID
NCT03495973
Treatments Being Tested